The stage of a lung cancer describes how large it is and how far it has spread. Staging guides treatment and gives a general sense of outlook. Non-small cell lung cancer is staged from 0 to 4 using the TNM system (tumor, nodes, metastasis). Small cell lung cancer is often described more simply as limited stage or extensive stage. Lower stages are more localized; higher stages have spread farther.
After a lung cancer diagnosis, one of the first questions is: what stage is it? Staging is how the care team turns scans and biopsies into a treatment plan. It answers three questions — how big the tumor is, whether it has reached nearby lymph nodes, and whether it has spread to other parts of the body — and it is the single strongest predictor of how the cancer is likely to behave and what treatments make sense. Understanding the basics can make conversations with the medical team far less overwhelming, and can help patients and families ask questions.
How is lung cancer staged?
Lung cancer staging uses a combination of tests, chosen based on the individual situation. The goal is to map the full extent of the cancer before deciding on treatment.
- CT scan. A detailed scan of the chest and usually the abdomen to measure the tumor and check nearby structures and lymph nodes.
- PET-CT scan. A whole-body scan that highlights areas of active cancer, often used to look for spread beyond the chest.
- Brain MRI. Frequently done because lung cancer can spread to the brain, sometimes before causing symptoms.
- Biopsy. A tissue sample of the tumor — and sometimes of lymph nodes — examined under a microscope to confirm cancer and identify its type.
- Lymph node sampling. Procedures such as endobronchial ultrasound (EBUS) or mediastinoscopy sample the lymph nodes in the center of the chest, which is critical for accurate lung cancer staging.
The results are combined into a stage. Two main types of lung cancer are staged differently because they behave differently: non-small cell lung cancer (NSCLC), which makes up about 80–85% of cases, and small cell lung cancer (SCLC), which makes up about 10–15% and tends to grow and spread more quickly.
Getting lung cancer staging right before treatment matters, because the stage determines the whole plan. Imaging can suggest where cancer has spread, but sampling lymph nodes directly — by EBUS or mediastinoscopy — is often what confirms it, which is why the team may recommend these procedures even when scans look clear. Taking the time to stage thoroughly helps avoid under-treating or over-treating the cancer.
What is the TNM staging system?
Non-small cell lung cancer is staged with the TNM system, the international standard maintained in the AJCC staging manual. Each letter captures one piece of the picture, and together they define the overall stage.
| Letter | What it measures | Examples |
| T (Tumor) | The size of the tumor and whether it has grown into nearby structures | A small tumor confined to the lung vs. one that has invaded the chest wall or a main airway |
| N (Nodes) | Whether and where cancer has reached lymph nodes | No node involvement vs. spread to lymph nodes in the center of the chest |
| M (Metastasis) | Whether cancer has spread to distant parts of the body | Confined to the chest vs. spread to the brain, bones, liver, or the other lung |
The care team combines the T, N, and M values into an overall stage from 0 to 4, and stages are sometimes divided further (for example, 3A, 3B, 3C) to fine-tune treatment. The same TNM information follows a patient throughout their care, which is why it appears repeatedly in the medical record and in conversations with different specialists.
What do the stages of non-small cell lung cancer mean?
Here is what each NSCLC stage generally means and how it is usually approached. These are general descriptions; the exact plan depends on the individual.
- Stage 0 (carcinoma in situ). Abnormal cells are confined to the lining of the airway and have not grown into deeper tissue. Often curable, sometimes with limited surgery or airway-directed treatment.
- Stage 1. A small tumor confined to the lung, with no spread to lymph nodes. Usually treated with the goal of cure, most often by surgery, or by precise radiation if surgery is not an option.
- Stage 2. A larger tumor and/or limited spread to lymph nodes on the same side within or near the lung. Often still treatable with the goal of cure, sometimes adding chemotherapy, immunotherapy, or targeted therapy before or after surgery.
- Stage 3. Cancer has spread to lymph nodes in the center of the chest or grown into nearby structures but has not reached distant organs. This is a complex group often treated with a combination of chemotherapy, radiation, surgery, immunotherapy or targeted therapy, planned by a multidisciplinary team.
- Stage 4. Cancer has spread to the other lung, to the fluid around the lung or heart, or to distant organs such as the brain, bones, or liver. Treatment focuses on controlling the cancer and maintaining quality of life, increasingly with targeted therapy and immunotherapy matched to the tumor’s biomarkers. Many people live longer and better with stage 4 disease than was possible in the past.
How is small cell lung cancer staged?
Small cell lung cancer grows and spreads quickly, so doctors often use a simpler two-part system alongside TNM, because it maps closely to how the disease is treated:
- Limited stage. Cancer is confined to one side of the chest and can be encompassed within a single radiation field. It is often treated with chemotherapy and radiation given together, followed by immunotherapy, with the goal of long-term control.
- Extensive stage. Cancer has spread more widely — to the other lung, to lymph nodes on the other side of the chest, or to distant parts of the body. It is often treated with chemotherapy combined with immunotherapy.
Because small cell lung cancer can progress rapidly, treatment usually begins soon after diagnosis and staging.
How does stage affect survival and outlook?
Stage strongly influences outlook, but it is only part of the picture — the type of cancer, its biomarkers, a person’s overall health, and how the cancer responds to treatment all matter. Survival statistics describe large groups of people, not any one individual, and they cannot predict how a particular person will do.
For non-small cell lung cancer (NSCLC), the American Cancer Society reports survival using the SEER database, which groups cancers as localized, regional, or distant rather than by numbered stage. The figures below are based on people diagnosed in 2015–2021 and do not yet reflect the newest treatments, so real-world outcomes for people diagnosed today may be better.
| SEER stage (how far it has spread) | NSCLC 5-year relative survival |
| Localized (confined to the lung) | About 65% |
| Regional (nearby nodes or structures) | About 37% |
| Distant (spread to other organs) | About 9% |
| All stages combined | About 28% |
Small cell lung cancer is staged differently, so it is shown on its own. Doctors describe it as limited stage or extensive stage, and 5-year survival figures for these come from the National Cancer Institute and clinical studies rather than the SEER summary-stage groupings used above. These figures are approximate and vary between studies – they may not reflect the most recent advances.
| Small cell lung cancer stage | 5-year survival |
| Limited stage (confined to one side of the chest) | About 20% |
| Extensive stage (spread more widely) | About 3% |
| All cases combined | About 7% |
Two points are worth emphasizing. First, survival is much higher when lung cancer is found early — which is the case for cancers caught by screening or incidental findings. Second, these numbers are improving. Thanks to research, five-year relative survival for regional-stage lung cancer rose from about 20% to 37%, and for distant-stage from about 2% to 10%, between the mid-1990s and recent years, according to the American Cancer Society. That progress is the direct result of new treatments developed through research.
How long does lung cancer staging take?
Staging usually takes from several days to a couple of weeks, depending on which tests are needed and how quickly they can be scheduled. The wait can feel frustrating at an already stressful time, but completing the right tests is what allows the team to recommend the most effective treatment. If the timeline worries you, ask your care team what to expect and whom to contact with questions.
Can the same cancer be staged differently by different doctors?
Staging follows a standardized international system, so the same information should lead to the same stage. Differences usually come from having different information — for example, one team may have additional biopsy results or a brain MRI that another did not. This is one reason a second opinion can be valuable for a complex diagnosis: it can confirm the stage and the plan, or bring new information to light.
Why does lung cancer staging matter for treatment?
Stage determines both the goal and the tools of treatment. Early-stage cancer is generally treated with the goal of cure, often with surgery or precise radiation. Locally advanced (stage 3) cancer usually calls for a carefully sequenced combination of therapies. Advanced (stage IV) cancer is treated to control the disease and preserve quality of life, increasingly with targeted therapy and immunotherapy guided by biomarker testing.
Whatever the stage, biomarker testing of the tumor is now a standard step, because it can reveal treatments matched to the specific cancer — and it can change the plan even for earlier-stage disease. Learn more about lung cancer treatment options and biomarker testing.
What questions should you ask about your stage?
- What is the stage of my cancer, and what does that mean in plain terms?
- Is the goal of treatment to cure the cancer or to control it?
- Has my tumor been tested for biomarkers, and how will the results affect my options?
- What treatments do you recommend for this stage, and why?
- Is a clinical trial an option for me?
Clinical stage vs. pathologic stage
You may hear two versions of a stage. The clinical stage is the team’s best estimate before surgery, based on physical exams, imaging, and biopsies. The pathologic stage (also called the surgical stage) is determined after surgery, when a pathologist examines the tumor and lymph nodes that were removed, and it is generally more precise. The two can differ — for example, surgery may reveal cancer in lymph nodes that imaging did not detect. Both are normal parts of the process, and the pathologic stage, when available, gives the most accurate picture.
What does ‘operable’ or ‘resectable’ mean?
These terms describe whether surgery is a realistic option. ‘Resectable’ means the tumor can be removed surgically; ‘unresectable’ means it cannot be fully removed, usually because of where it is or how far it has spread. ‘Operable’ also takes the person into account — whether their overall health and lung function would allow them to undergo and recover from surgery. A cancer can be technically resectable while a person is not a candidate for surgery, in which case precise radiation and other treatments may be used instead. These determinations are made by the surgical and oncology team together.
What is restaging, and what is a recurrence?
The stage assigned at diagnosis does not change, but doctors may reassess the cancer during or after treatment to see how it is responding — sometimes called restaging. If lung cancer comes back after a period of being controlled or undetectable, it is called a recurrence, which may be local (near the original site) or distant (in another part of the body). A recurrence is evaluated with its own scans and often repeat biomarker testing, because treatment options may have changed since the first diagnosis.
Is cancer stage the same as cancer grade?
No — and the two are easy to confuse. Stage describes how far the cancer has spread. Grade describes how abnormal the cancer cells look under the microscope and how quickly they are likely to grow, based on the biopsy. A pathologist assigns the grade, and it is one of several details — along with stage, type, and biomarkers — that the care team uses to understand a particular cancer and plan treatment. A cancer can be early-stage but higher-grade, or the reverse, which is why doctors look at the full picture rather than any single number.
Stages of lung cancer FAQ
What are the four stages of lung cancer?
Non-small cell lung cancer is grouped into stages 1 through 4 (plus stage 0). Stage 1 is a small tumor confined to the lung; stage 2 involves a larger tumor or nearby nodes; stage 3 has spread to lymph nodes in the center of the chest or nearby structures; stage 4 has spread to distant organs.
What is stage 4 lung cancer?
Stage 4 (metastatic) lung cancer has spread beyond the lung to the other lung, the fluid around the lung or heart, or distant organs such as the brain, bones, or liver. It is treated to control the cancer and maintain quality of life, often with targeted therapy or immunotherapy.
Which lung cancer stage is most treatable?
Earlier stages are the most treatable. Stage 0 and stage 1 lung cancers are often treated with the goal of cure, and survival is highest when the cancer is found before it spreads.
What’s the difference between limited and extensive stage?
These terms are used for small cell lung cancer. Limited stage is confined to one side of the chest and can be treated within a single radiation field; extensive stage has spread more widely or to distant parts of the body.
Can the stage of lung cancer change?
The stage assigned at diagnosis does not change, even if the cancer later grows or shrinks. Doctors refer to the original stage along with how the cancer is responding. If cancer returns after treatment, it is described as a recurrence.
How do doctors determine the stage?
Through a combination of imaging (CT, PET-CT, often brain MRI), a biopsy, and sometimes lymph node sampling such as EBUS or mediastinoscopy. The results are combined into a TNM stage.
Is stage the same as type of lung cancer?
No. Type refers to what kind of cancer it is (such as non-small cell or small cell), while stage refers to how far it has spread. Both are needed to plan treatment.
Does a higher stage always mean a worse outcome?
A higher stage generally means the cancer has spread farther and is harder to cure, but outcome also depends on the cancer’s type and biomarkers, the person’s health, and how well the cancer responds to treatment. Newer treatments have improved outcomes even at advanced stages, so stage alone does not determine what is possible.
Lung cancer staging tells you where things stand today. Research is what changes what’s possible tomorrow — and it’s why survival at every stage is improving. Your support funds lung cancer research.
This page is for general education and is not a substitute for professional medical advice. Talk with your own health care team about your diagnosis, symptoms, and treatment options.
Sources
- American Cancer Society. Lung Cancer Stages (TNM) and Non-Small Cell Lung Cancer Stages. cancer.org, 2025.
- American Cancer Society. Lung Cancer Survival Rates. cancer.org, 2026 (SEER, 2015–2021).
- American Cancer Society. Cancer Statistics, 2026. CA: A Cancer Journal for Clinicians, 2026.
- National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ) — Stage Information. cancer.gov.
- National Cancer Institute. Small Cell Lung Cancer Treatment (PDQ). cancer.gov.